pemigatinib · Medicine question

What type of cancer is Pemazyre (pemigatinib) approved to treat in adults?

Name: What type of cancer is Pemazyre (pemigatinib) approved to treat in adults?
Published: 2026-11-08T02:00:25.877Z

iatroX medicinesPublished 8 November 2026

The answer

Answer

Pemazyre (pemigatinib) monotherapy is indicated for adults with locally advanced or metastatic cholangiocarcinoma with an FGFR2 fusion or rearrangement that has progressed after at least one prior line of systemic therapy.

Sources for this answer

Pemazyre 4.5 mg - tabletsIncyte Biosciences UK Ltd · emc · SmPC §4.1 Therapeutic Indications · Version 5Document updated 3 February 2026

Sources checked 8 November 2026

loading page…

Answer

Sources for this answer

Answer

Sources for this answer

More questions about pemigatinib